All News
Filter News
Found 16,616 articles
-
Xenogen Corporation Announces Extension Of Global Licensing Agreement With Novartis Corporation
12/7/2005
-
The Day In Review: Big Pharma Licenses Drugs From Biotech
12/7/2005
-
Novartis Pharmaceuticals Corporation And Astex Therapeutics Ink $520 Million Cancer Drug Deal
12/6/2005
-
Clarus Ventures, A Life Sciences Venture Capital Firm, Announces Closing Of $500 Million First Fund
12/6/2005
-
Chiron Corporation Release: U.S. Federal Trade Commission Approves Early Termination Of Hart-Scott-Rodino Waiting Period
12/6/2005
-
QLT Inc. To Host Conference Call To Discuss Strategic Update
12/6/2005
-
Genzyme Corporation Launches Colorectal Cancer Test To Determine Appropriate Camptosar(R) Dosage
12/6/2005
-
Tanox, Inc. Co-Founder To Step Down As President, CEO
12/5/2005
-
Eisai Inc. Release: Data Evaluating The Safety And Efficacy Of Anti-epileptic Drug Rufinamide Presented At American Epilepsy Society
12/5/2005
-
Idenix Pharmaceuticals, Inc. Provides Update On Clinical Development Program For Valopicitabine (NM283) For The Treatment Of Hepatitis C
12/2/2005
-
Lentigen Corporation Appoints Experienced Management Team
12/2/2005
-
OncoMed Pharmaceuticals, Inc. Appoints Paul J. Hastings President And Chief Executive Officer
12/1/2005
-
Sirtris Pharmaceuticals Hires Peter Elliott As SVP, Head Of Development
11/30/2005
-
Novartis Corporation Issues Breast Cancer Drug Warning
11/29/2005
-
Novartis Corporation Sells Dietary Food Unit For $259 Million
11/29/2005
-
FDA Approves Novartis Corporation's Trileptal(R) As Adjunctive Therapy In Children As Young As Two
11/28/2005
-
Anadys Pharmaceuticals, Inc. To Present At Lazard Capital Markets Annual Life Sciences Conference
11/23/2005
-
FDA Wants Stronger Asthma Drug Warnings On GlaxoSmithKline's Advair, Serevent And Novartis Pharma AG's Foradil
11/21/2005
-
The Day In Review: FDA News And A Big Drug Deal
11/21/2005
-
Dr. Robert Bast Joins Tanox, Inc. Scientific Advisory Board
11/21/2005